Latvia vs New Zealand: Proportion of isolates with decreased susceptibility or resistance
Latvia
0
in 2018
New Zealand
0.4386
in 2017
Latvia rank
25th
New Zealand rank
22nd
Proportion of isolates with decreased susceptibility or resistance over time
- Latvia
- New Zealand
How they compare
New Zealand currently reports 0.4386 against 0 in Latvia, a difference of 0.4386.
The two have swapped places 2 times across 9 shared years of data; in 2009 it was New Zealand ahead.
Latvia ranks 25th and New Zealand ranks 22nd of 51 countries.
Latvia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | — |
| 2010s | 0.6495 | 0.3595 | 0.2899 | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Latvia or New Zealand?
- New Zealand, at 0.4386 against 0 in Latvia as of 2017.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Latvia and New Zealand?
- 0.4386, with New Zealand ahead.
- How many years of comparable data are there for Latvia and New Zealand?
- 9 years are reported by both, from 2009 to 2017.
- How do Latvia and New Zealand rank globally for proportion of isolates with decreased susceptibility or resistance?
- Latvia ranks 25th and New Zealand ranks 22nd of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.